Morgan Lewis partner Michael Abernathy spoke with Business Insurance for an article about the pharmaceutical industry’s efforts to produce a COVID-19 vaccine. In the piece, Mike discussed the intellectual property risks companies need to consider and the need to rapidly do clearance as they are working on the vaccine.